CF Foundation | Claire Tinsley

Published on november 5, 2019 by

Claire Tinsley, an adult with cystic fibrosis, talks about her hopes for the triple-combination modulator elexacaftor/tezacaftor/ivacaftor (Trikafta™) and how the drug might improve her health. She has one F508del mutation and one nonsense mutation.


Add your comment

Your email address will not be published.